

Elevated LDL-C: The importance of early intervention

A short animation highlighting the consequences of long-term exposure to persistently elevated LDL-C.
LDL-C, low-density lipoprotein cholesterol.
UK | March 2025 | FA-11361470
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.